Literature DB >> 18281275

Autoproteolytic cleavage and activation of human acid ceramidase.

Nataly Shtraizent1, Efrat Eliyahu, Jae-Ho Park, Xingxuan He, Ruth Shalgi, Edward H Schuchman.   

Abstract

Herein we report the mechanism of human acid ceramidase (AC; N-acylsphingosine deacylase) cleavage and activation. A highly purified, recombinant human AC precursor underwent self-cleavage into alpha and beta subunits, similar to other members of the N-terminal nucleophile hydrolase superfamily. This reaction proceeded with first order kinetics, characteristic of self-cleavage. AC self-cleavage occurred most rapidly at acidic pH, but also at neutral pH. Site-directed mutagenesis and expression studies demonstrated that Cys-143 was an essential nucleophile that was required at the cleavage site. Other amino acids participating in AC cleavage included Arg-159 and Asp-162. Mutations at these three amino acids prevented AC cleavage and activity, the latter assessed using BODIPY-conjugated ceramide. We propose the following mechanism for AC self-cleavage and activation. Asp-162 likely forms a hydrogen bond with Cys-143, initiating a conformational change that allows Arg-159 to act as a proton acceptor. This, in turn, facilitates an intermediate thioether bond between Cys-143 and Ile-142, the site of AC cleavage. Hydrolysis of this bond is catalyzed by water. Treatment of recombinant AC with the cysteine protease inhibitor, methyl methanethiosulfonate, inhibited both cleavage and enzymatic activity, further indicating that cysteine-mediated self-cleavage is required for ceramide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281275      PMCID: PMC2431059          DOI: 10.1074/jbc.M709166200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Peptidase family U34 belongs to the superfamily of N-terminal nucleophile hydrolases.

Authors:  Jimin Pei; Nick V Grishin
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain.

Authors:  Yu Huang; Hitoshi Tanimukai; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

3.  Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling.

Authors:  Jose Antonio Chavez; William L Holland; Julia Bär; Konrad Sandhoff; Scott A Summers
Journal:  J Biol Chem       Date:  2005-03-17       Impact factor: 5.157

Review 4.  Current perspective on the role of apoptosis in atherothrombotic disease.

Authors:  Z Mallat; A Tedgui
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

5.  Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

Authors:  M Selzner; A Bielawska; M A Morse; H A Rüdiger; D Sindram; Y A Hannun; P A Clavien
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Human acid ceramidase is overexpressed but not mutated in prostate cancer.

Authors:  R S Seelan; C Qian; A Yokomizo; D G Bostwick; D I Smith; W Liu
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

7.  Human acid ceramidase: processing, glycosylation, and lysosomal targeting.

Authors:  K Ferlinz; G Kopal; K Bernardo; T Linke; J Bar; B Breiden; U Neumann; F Lang; E H Schuchman; K Sandhoff
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

8.  Purification and characterization of recombinant, human acid ceramidase. Catalytic reactions and interactions with acid sphingomyelinase.

Authors:  Xingxuan He; Nozomu Okino; Rajwinder Dhami; Arie Dagan; Shimon Gatt; Heike Schulze; Konrad Sandhoff; Edward H Schuchman
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

9.  Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death.

Authors:  A Strelow; K Bernardo; S Adam-Klages; T Linke; K Sandhoff; M Krönke; D Adam
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  32 in total

1.  Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.

Authors:  Jay M West; Nikolai Zvonok; Kyle M Whitten; Jodianne T Wood; Alexandros Makriyannis
Journal:  J Proteome Res       Date:  2012-01-03       Impact factor: 4.466

2.  Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.

Authors:  Aiping Bai; Zdzislaw M Szulc; Jacek Bielawski; Jason S Pierce; Barbara Rembiesa; Silva Terzieva; Cungui Mao; Ruijuan Xu; Bill Wu; Christopher J Clarke; Benjamin Newcomb; Xiang Liu; James Norris; Yusuf A Hannun; Alicja Bielawska
Journal:  Bioorg Med Chem       Date:  2014-10-22       Impact factor: 3.641

3.  Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression.

Authors:  Natasha C Lucki; Sibali Bandyopadhyay; Elaine Wang; Alfred H Merrill; Marion B Sewer
Journal:  Mol Endocrinol       Date:  2012-01-19

Review 4.  The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.

Authors:  Su-Fern Tan; Jennifer M Pearson; David J Feith; Thomas P Loughran
Journal:  Expert Opin Ther Targets       Date:  2017-05-02       Impact factor: 6.902

5.  Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization.

Authors:  Efrat Eliyahu; Nataly Shtraizent; Kurt Martinuzzi; Jason Barritt; Xingxuan He; Hong Wei; Sanjeev Chaubal; Alan B Copperman; Edward H Schuchman
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

6.  Acid ceramidase as a therapeutic target in metastatic prostate cancer.

Authors:  Luz Camacho; Oscar Meca-Cortés; José Luis Abad; Simón García; Nuria Rubio; Alba Díaz; Toni Celià-Terrassa; Francesca Cingolani; Raquel Bermudo; Pedro L Fernández; Jerónimo Blanco; Antonio Delgado; Josefina Casas; Gemma Fabriàs; Timothy M Thomson
Journal:  J Lipid Res       Date:  2013-02-19       Impact factor: 5.922

7.  The human asparaginase-like protein 1 hASRGL1 is an Ntn hydrolase with beta-aspartyl peptidase activity.

Authors:  Jason R Cantor; Everett M Stone; Lynne Chantranupong; George Georgiou
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

8.  Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.

Authors:  Carlos Solorzano; Chenggang Zhu; Natalia Battista; Giuseppe Astarita; Alessio Lodola; Silvia Rivara; Marco Mor; Roberto Russo; Mauro Maccarrone; Francesca Antonietti; Andrea Duranti; Andrea Tontini; Salvatore Cuzzocrea; Giorgio Tarzia; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

9.  Mechanistic insights into the hydrolysis and synthesis of ceramide by neutral ceramidase.

Authors:  Tsuyoshi Inoue; Nozomu Okino; Yoshimitsu Kakuta; Atsushi Hijikata; Hiroyuki Okano; Hatsumi M Goda; Motohiro Tani; Noriyuki Sueyoshi; Kouji Kambayashi; Hiroyoshi Matsumura; Yasushi Kai; Makoto Ito
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

10.  Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites.

Authors:  Aiping Bai; Alicja Bielawska; Mehrdad Rahmaniyan; Jacqueline M Kraveka; Jacek Bielawski; Yusuf A Hannun
Journal:  Bioorg Med Chem       Date:  2018-11-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.